The Food and Drug Administration (FDA) has approved Arbli™, an oral suspension formulation of losartan potassium. Arbli, an angiotensin II receptor blocker, is indicated for the treatment of ...

SCIENTURE announces the U.S. FDA Approval of its NDA for SCN-102, to be launched as ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL. The global market for losartan potassium was ...

Arbli is supplied as an peppermint-flavored oral suspension containing 10mg/mL of losartan potassium in 165mL bottles. The Food and Drug Administration (FDA) has approved Arbli ™, an oral ...

Losartan is a prescription drug to treat high blood pressure, diabetic nephropathy, and stroke risk. Learn about side effects, warnings, dosage, and more.

Macleods Pharmaceuticals Limited recalled 32 lots of blood pressure medication losartan after discovering trace amounts of a carcinogen.

The losartan market is anticipated to expand at a CAGR of 4% between 2024 and 2034. The global losartan market is experiencing significant growth driven by several key factors.

New research led by investigators at Massachusetts General Hospital (MGH) reveals that the blood pressure drug losartan can prevent immunotherapy-induced edema.

Learn about side effects, how to take, and more of losartan oral tablet. It's a prescription drug that's used for certain conditions, including high blood pressure.

Research found that a common blood pressure medication -- losartan -- is not effective in reducing lung injury in patients with COVID-19.

/CNW/ - Summary Products: Irbesartan, losartan and valsartan drugs Issue: Several companies are recalling multiple lots of these products due to the presence ...

Losartan was also found to reduce inflammatory responses that would otherwise lead to acute respiratory distress and change the atomic configuration of SARS-CoV-2 PLpro.